CLINICAL EVALUATION AND MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA: A UROLOGICAL PERSPECTIVE

Authors

  • Hudayberdiyev Sadik Tursunovich   Department of Medical biology and histology,PhD Andijan State Medical Institute, Uzbekistan

Keywords:

urinary frequency, urgency, nocturia, weak stream.

Abstract

Benign prostatic hyperplasia (BPH) is a nonmalignant enlargement of the prostate gland commonly seen in aging men. It is one of the most prevalent causes of lower urinary tract symptoms (LUTS) and can significantly affect quality of life. This article presents an overview of the pathophysiology, diagnostic approaches, and contemporary treatment options for BPH, emphasizing recent advances in minimally invasive therapies. Accurate assessment and personalized management strategies are key to improving patient outcomes in urological practice.

References

Roehrborn CG. “Benign prostatic hyperplasia: an overview.” Rev Urol. 2005.

Gratzke C, et al. “EAU Guidelines on the Management of Non-Neurogenic Male LUTS.” Eur Urol. 2022.

McVary KT, et al. “Update on AUA guideline for management of benign prostatic hyperplasia.” J Urol. 2021.

Tutrone R, et al. “Minimally invasive treatments for benign prostatic hyperplasia: current perspectives.” Res Rep Urol. 2020.

Downloads

Published

2025-07-07

How to Cite

Hudayberdiyev Sadik Tursunovich . (2025). CLINICAL EVALUATION AND MANAGEMENT OF BENIGN PROSTATIC HYPERPLASIA: A UROLOGICAL PERSPECTIVE. Ethiopian International Multidisciplinary Research Conferences, 71–73. Retrieved from https://eijmr.org/conferences/index.php/eimrc/article/view/1096

Issue

2025: Ethiopian International Multidisciplinary Research Conferences

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.